Our finding of continuing rise of miR-34a with age suggests that either continuing acetyl-p53 increase overwhelming the SHP-binding or other putative factors involved, thus disable the FXR/SHP role in inhibiting this microRNA activation, and cause the absence of SIRT1 in many age-related metabolic diseases. Here, SIRT1 is linked to age.